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Rickettsia 
aeschlimannii: 
A New Pathogenic 
Spotted Fever 
Group Rickettsia, 
South Africa
To the Editor: Spotted fever
group rickettsiae are increasingly rec-
ognized as agents of disease in resi-
dents of and tourists to South Africa
(1). To date, two species, Rickettsia
conorii and R. africae, which cause
Mediterranean spotted fever (MSF)
and African tick-bite fever (ATBF),
respectively, have been associated
with human disease in the region;
ATBF is more frequently associated
with travel (1). As different antibiotic
regimens are recommended for the
two syndromes, differentiating MSF
from ATBF is important. Increasing
evidence shows that the syndromes
can usually be differentiated through
clinical manifestations and epidemio-
logic characteristics (1).
We recently encountered a South
African patient who, on returning
from a hunting and fishing trip, dis-
covered a Rhipicephalus appendicula-
tus tick attached to his right thigh and
an eschar around the attachment site.
The patient was aware of the risk of
tick-transmitted disease; after remov-
ing the tick, immediately self-pre-
scribed doxycycline. No further
symptoms developed. However, as a
precaution, the patient went to a local
clinic, where a skin biopsy was taken
from the eschar. This sample, together
with the removed tick, was submitted
to our laboratory. DNA extracts, pre-
pared from an eschar biopsy and the
tick, were incorporated into a poly-
merase chain reaction (PCR) assay
specifically targeting a fragment of the
rickettsial ompA (2). Sequence analy-
sis of the amplification products
showed both to be identical and to
share >99% similarity with the ompA
of R. aeschlimannii, a species not pre-
viously associated with human dis-
ease. Unfortunately, blood samples
could not be collected at the time the
patients first had symptoms; thus,
investigation of a disseminated infec-
tion by PCR and serologic testing was
not possible.
Although genotypically indistin-
guishable organisms had previously
been detected in Hyalomma mar-
ginatum collected in Portugal and
Zimbabwe, R. aeschlimannii was first
characterized following its isolation
from H. marginatum ticks in Morocco
(3) and recently in Niger  (4). This
encounter was the first demonstration
of its presence in South Africa and in
Rhipicephalus ticks.
A lack of suitable clinical material
prevented full evaluation of the patho-
genic potential of R. aeschlimannii in
this patient and prompt antibiotic
intervention may have prevented evo-
lution of the syndrome. Nonetheless,
that R. aeschlimannii was transmitted
to the patient and established a local
infection leading to eschar formation
provides clear, albeit preliminary, evi-
dence of its virulence. Until further
cases are encountered, allowing better
characterization of the clinical mani-
festations associated with R. aeschli-
mannii infection and considering the
agent capable of inducing either MSF
or ATBF-like manifestations is cru-
cial; neither of these syndromes can be
associated with a specific causative
agent without microbiologic identifi-
cation. Our findings demonstrate that
Rickettsia species first encountered in
tick surveys are associated with
human disease, and we should not
assume that some Rickettsia species
not have a pathogenic potential.
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Age as a Risk 
Factor for 
Cutaneous Human 
Anthrax: Evidence 
from Haiti, 
1973–1974
To the Editor: Few cases of
anthrax have been reported in chil-
dren, in part because most exposures
to Bacillus anthracis occur in work-
place settings. Questions about the
susceptibility of children to B. anthra-
cis infection were raised when cutane-
ous anthrax developed in a 7-month-